{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe IC<sub>50</sub>s were then converted to pK<sub>B</sub> values with the following formula: KB=IC50/1+EC60conc.of agonist used in assay/EC50agonist\nThe K<sub>i</sub> value for the unlabeled ligand was calculated using the Cheng-Prusoff equation (Biochem. Pharmacol. 22:3099-3108, 1973): where L is the concentration of the radioactive ligand used and K<sub>d</sub> is the affinity of the radioactive ligand for the receptor, determined by saturation binding.\nKi=I\u2062C50/1+L/Kd\nIn general, the compounds of the invention, which were tested, demonstrated statistically significant antagonistic activity at the NK<sub>1</sub> receptor within the range of 7-8 for the pK<sub>B</sub>.\nIn general, the compounds of the invention, which were tested, demonstrated statistically significant CYP3A4 inhibition at a low level. The IC<sub>50</sub> values tested according to Bapiro et al; Drug Metab. Dispos. 29, 30-35 (2001) were generally greater than 10 \u00b5M.\nIn general, the compounds of the invention, which were tested, demonstrated statistically significant hERG activity at a low level. The IC<sub>50</sub> values tested as described above were generally greater than 8 \u00b5M."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": "IC50", "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "Ki", "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "Ki", "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": "NK1 receptor", "binding_metric": "pKB", "value": "7-8", "unit": null}, {"molecule_name": null, "protein_target_name": "CYP3A4", "binding_metric": "IC50", "value": ">10", "unit": "\u00b5M"}, {"molecule_name": null, "protein_target_name": "hERG", "binding_metric": "IC50", "value": ">8", "unit": "\u00b5M"}]}
